Screening for Metabolic Syndrome in an Ethnic Minority Group in Hungary
Abstract Number: 1000-P
Authors: GY[Ouml]RGY JERMENDY, TIBOR HIDV[Eacute]GI, KATALIN HETY[Eacute]SI, LAJOS B[Iacute]R[Oacute]
Institutions: Gyor, Hungary; Budapest, Hungary
Results: The health status of the biggest ethnic minority group in Hungary was reported to be worse than that of the total population, therefore, it can be supposed that the prevalence rate of the metabolic syndrome is high among roma (gipsy) population. A screening procedure was initiated among gypsies (age 20-70 years) living in town Gyor and Tet. Subjects with known diabetes were excluded. At screening, anthropometric and physical investigations were performed followed by an oral glucose tolerance test with 75 g glucose. Blood glucose and fasting serum lipid values, CRP, fibrinogen and adiponectin were measured. The diganosis of the metabolic syndrome was based on ATP III criteria. Among 77 subjects screened (35 men, 42 women; age 46.9±10.6 years; x±SD) diabetes mellitus was found in 14 cases (18.2 %) while impaired glucose regulation (IFG, IGT) was observed in 14 cases (18.2 %). Components of the metabolic syndrome were found as follows: hypertension 47 cases (61.0 %), abnormal waist circumference 40 cases (51.9 %), abnormal HDL-cholesterol 39 cases (50.6 %), abnormal serum triglycerides 35 cases (45.5 %) and abnormal fasting blood glucose 15 cases (19.5 %). Metabolic syndrome was diagnosed in 39 subjects (50.6 %) with no significant predominance in gender. Some clinical characteristics and laboratory findings that are not presented in the ATP III diagnostic criteria regarding subjects with (n=39) versus without (n=38) metabolic syndrome (MS) are shown in table 1.
In order to prevent the cardiovascular consequences of the metabolic syndrome and to prevent the development of the metabolic syndrome itself, continuous health promotion should be provided for gipsy population in Hungary.
|Age (years)||BMI (kg/m2)||HOMA||Postchallenge insulin (μU/ml)||CRP (mg/l)||Fibrinogen (g/l)||Apidonectin (ng/ml)|